Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?
Junshuai Xue,1,* Delin Ma,2,* Jianjun Jiang,1 Yang Liu1 1Department of General Surgery, Vascular Surgery, Shandong University Qilu Hospital, Jinan City, Shandong Province, People’s Republic of China; 2Department of General Surgery, Shandong University Qilu Hospital, Jinan City, Shand...
Guardado en:
Autores principales: | Xue J, Ma D, Jiang J, Liu Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08d73b687aea4c188fbf192c422c7494 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019) -
Identification of four hub genes in venous thromboembolism via weighted gene coexpression network analysis
por: Guoju Fan, et al.
Publicado: (2021) -
Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review
por: Sandra Lee, et al.
Publicado: (2021) -
Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
por: Alhasson H, et al.
Publicado: (2021) -
Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer
por: Liu F, et al.
Publicado: (2021)